Showing results (1-10 of 120) with videos related to
Sort By:
Pageof 12
Blood|June 26, 2004
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemiaWilliam Tse, Soheil Meshinchi, Todd A Alonzo, et al.Blood|February 22, 2003
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimenJerald P Radich, Ted Gooley, William Bensinger, et al.Blood|November 23, 2006
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemiaPaul A Carpenter, David S Snyder, Mary E D Flowers, et al.Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.Blood|July 13, 2013
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remissionRoland B Walter, Sarah A Buckley, John M Pagel, et al.Blood|October 13, 2017
Gemtuzumab ozogamicin for acute myeloid leukemiaFrederick R Appelbaum, Irwin D BernsteinBlood|August 24, 2012
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemiaJerald P Radich, Kenneth J Kopecky, Frederick R Appelbaum, et al.Blood|January 12, 2012
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantationBart L Scott, Ted A Gooley, Mohamed L Sorror, et al.Pageof 12